Engineered pseudoislets for improved survival and engraftment in islet transplant for diabetes

Size-controlled pseudoislets manufactured using the AggreWell platform address the key barriers in islet transplantation: heterogeneity and poor vascularization. By producing uniform organoids that resist hypoxia and rev...